Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cannabidiol Oral Solution as Adjunctive Therapy in Infantile Spasms
NCT03421496Phase 3Terminated
- Start
- Sep 2018
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of cannabidiol in infantile epileptic spasms syndrome (IESS). Started Sep 2018; status: terminated.
02
Drugs
cannabidiol
03
Conditions
infantile epileptic spasms syndrome (IESS)
Beyond the preview
Go deeper on NCT03421496.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03421496.